Vesalius Longevity Labs Secures $25 Million To Expand Global Market Presence
Vesalius Longevity Labs (CSE: VLAB) (@Vesalius_Longevity), a longevity and regenerative health platform focused on peptides, biologics, and preventative healthcare, raised $25 million . Headquartered in Scottsdale, Ar…
Vesalius Longevity Labs (CSE: VLAB) (@Vesalius_Longevity), a longevity and regenerative health platform focused on peptides, biologics, and preventative healthcare, raised $25 million. Headquartered in Scottsdale, Arizona, and Vancouver, British Columbia, the company operates a proprietary ecosystem that connects healthcare providers with compliant pharmacies and provides access to therapies, education, and partnerships. Vesalius plans to begin manufacturing its own Peptual® “Made-in-the-USA” peptide APIs to supply compounding pharmacies domestically and internationally. The raise included investors David Adelman, Harvey Spevak, Kevin Mayer, David Blitzer, Dana White, Gary Brecka and Brigham Buhler. James McRoberts founded the company.
FUN FACTS: The company will use the capital to expand its sales team, enter new global markets, and meet growing demand for safe, regulated access to longevity therapies.
FOUNDER: James McRoberts
INVESTORS: David Adelman (@DavidAdelman), Harvey Spevak (@hspevak), Kevin Mayer (@KevinMayer), David Blitzer, Dana White (@DanaWhite), Gary Brecka (@GaryBrecka), Brigham Buhler (@brigham.buhler)
AMOUNT: $25,000,000
HQ: Scottsdale, Arizona & Vancouver, British Columbia
#VentureCapital #VesaliusLongevityLabs #TradedPartner #TradedVC
ABOUT THE DEAL
- Raise
- $13M
- Round
- Not stated
- Company
- Vesalius Longevity Labs
- Desk
- Deals
- Filed
- Nov 19, 2026
- Founders
- Investors
- David Adelman (@DavidAdelman)
- Harvey Spevak (@hspevak)
- Kevin Mayer (@KevinMayer)
- David Blitzer
- Dana White (@DanaWhite)
- Gary Brecka (@GaryBrecka)
- Brigham Buhler (@brigham.buhler)